ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TBX2
|
ENSG00000121068.9 | TBX2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TBX2 | hg19_v2_chr17_+_59477233_59477263 | 0.19 | 4.7e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_100111580 | 1.70 |
ENST00000605497.1 |
PALMD |
palmdelphin |
chr1_-_79472365 | 1.62 |
ENST00000370742.3 |
ELTD1 |
EGF, latrophilin and seven transmembrane domain containing 1 |
chr2_-_175870085 | 1.44 |
ENST00000409156.3 |
CHN1 |
chimerin 1 |
chr1_+_100111479 | 1.41 |
ENST00000263174.4 |
PALMD |
palmdelphin |
chr2_-_175869936 | 1.40 |
ENST00000409900.3 |
CHN1 |
chimerin 1 |
chr12_+_75874984 | 1.37 |
ENST00000550491.1 |
GLIPR1 |
GLI pathogenesis-related 1 |
chrX_+_99899180 | 1.36 |
ENST00000373004.3 |
SRPX2 |
sushi-repeat containing protein, X-linked 2 |
chrY_+_2709527 | 1.34 |
ENST00000250784.8 |
RPS4Y1 |
ribosomal protein S4, Y-linked 1 |
chr3_-_120170052 | 1.30 |
ENST00000295633.3 |
FSTL1 |
follistatin-like 1 |
chr10_+_54074033 | 1.25 |
ENST00000373970.3 |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
chr1_+_101702417 | 1.25 |
ENST00000305352.6 |
S1PR1 |
sphingosine-1-phosphate receptor 1 |
chrY_+_2709906 | 1.18 |
ENST00000430575.1 |
RPS4Y1 |
ribosomal protein S4, Y-linked 1 |
chr18_-_52969844 | 1.18 |
ENST00000561831.3 |
TCF4 |
transcription factor 4 |
chr12_-_49318715 | 1.13 |
ENST00000444214.2 |
FKBP11 |
FK506 binding protein 11, 19 kDa |
chrX_+_114795489 | 1.11 |
ENST00000355899.3 ENST00000537301.1 ENST00000289290.3 |
PLS3 |
plastin 3 |
chr8_-_27457494 | 1.10 |
ENST00000521770.1 |
CLU |
clusterin |
chrX_+_51636629 | 0.89 |
ENST00000375722.1 ENST00000326587.7 ENST00000375695.2 |
MAGED1 |
melanoma antigen family D, 1 |
chr6_+_121756809 | 0.87 |
ENST00000282561.3 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
chr2_+_33701286 | 0.86 |
ENST00000403687.3 |
RASGRP3 |
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr15_+_25200074 | 0.84 |
ENST00000390687.4 ENST00000584968.1 ENST00000346403.6 ENST00000554227.2 |
SNRPN |
small nuclear ribonucleoprotein polypeptide N |
chr11_-_615570 | 0.77 |
ENST00000525445.1 ENST00000348655.6 ENST00000397566.1 |
IRF7 |
interferon regulatory factor 7 |
chr15_+_25200108 | 0.76 |
ENST00000577949.1 ENST00000338094.6 ENST00000338327.4 ENST00000579070.1 ENST00000577565.1 |
SNURF SNRPN |
SNRPN upstream reading frame protein small nuclear ribonucleoprotein polypeptide N |
chr3_-_66551397 | 0.75 |
ENST00000383703.3 |
LRIG1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
chr9_+_124048864 | 0.73 |
ENST00000545652.1 |
GSN |
gelsolin |
chr2_+_201994042 | 0.72 |
ENST00000417748.1 |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
chr21_+_30502806 | 0.71 |
ENST00000399928.1 ENST00000399926.1 |
MAP3K7CL |
MAP3K7 C-terminal like |
chr2_+_201994208 | 0.70 |
ENST00000440180.1 |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
chr4_-_186732048 | 0.69 |
ENST00000448662.2 ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2 |
sorbin and SH3 domain containing 2 |
chr3_-_66551351 | 0.69 |
ENST00000273261.3 |
LRIG1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
chr8_-_17533838 | 0.68 |
ENST00000400046.1 |
MTUS1 |
microtubule associated tumor suppressor 1 |
chr1_-_52456352 | 0.66 |
ENST00000371655.3 |
RAB3B |
RAB3B, member RAS oncogene family |
chr22_+_31003190 | 0.62 |
ENST00000407817.3 |
TCN2 |
transcobalamin II |
chr22_+_35776828 | 0.62 |
ENST00000216117.8 |
HMOX1 |
heme oxygenase (decycling) 1 |
chr1_-_150780757 | 0.60 |
ENST00000271651.3 |
CTSK |
cathepsin K |
chr1_-_22263790 | 0.59 |
ENST00000374695.3 |
HSPG2 |
heparan sulfate proteoglycan 2 |
chr17_-_7590745 | 0.58 |
ENST00000514944.1 ENST00000503591.1 ENST00000455263.2 ENST00000420246.2 ENST00000445888.2 ENST00000509690.1 ENST00000604348.1 ENST00000269305.4 |
TP53 |
tumor protein p53 |
chr20_-_50385138 | 0.58 |
ENST00000338821.5 |
ATP9A |
ATPase, class II, type 9A |
chr5_-_55290773 | 0.56 |
ENST00000502326.3 ENST00000381298.2 |
IL6ST |
interleukin 6 signal transducer (gp130, oncostatin M receptor) |
chr8_+_82192501 | 0.55 |
ENST00000297258.6 |
FABP5 |
fatty acid binding protein 5 (psoriasis-associated) |
chr17_+_26662730 | 0.53 |
ENST00000226225.2 |
TNFAIP1 |
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr4_+_124317940 | 0.50 |
ENST00000505319.1 ENST00000339241.1 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
chr3_-_105588231 | 0.47 |
ENST00000545639.1 ENST00000394027.3 ENST00000438603.1 ENST00000447441.1 ENST00000443752.1 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
chr22_+_31003133 | 0.46 |
ENST00000405742.3 |
TCN2 |
transcobalamin II |
chr22_+_38597889 | 0.46 |
ENST00000338483.2 ENST00000538320.1 ENST00000538999.1 ENST00000441709.1 |
MAFF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
chr4_-_186456766 | 0.44 |
ENST00000284771.6 |
PDLIM3 |
PDZ and LIM domain 3 |
chr1_+_38022572 | 0.44 |
ENST00000541606.1 |
DNALI1 |
dynein, axonemal, light intermediate chain 1 |
chr11_-_615942 | 0.44 |
ENST00000397562.3 ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
IRF7 |
interferon regulatory factor 7 |
chr1_+_213123976 | 0.43 |
ENST00000366965.2 ENST00000366967.2 |
VASH2 |
vasohibin 2 |
chr3_-_49377499 | 0.43 |
ENST00000265560.4 |
USP4 |
ubiquitin specific peptidase 4 (proto-oncogene) |
chrX_-_10645773 | 0.43 |
ENST00000453318.2 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
chr12_-_15104040 | 0.43 |
ENST00000541644.1 ENST00000545895.1 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
chr7_-_99766191 | 0.42 |
ENST00000423751.1 ENST00000360039.4 |
GAL3ST4 |
galactose-3-O-sulfotransferase 4 |
chr17_-_39968406 | 0.41 |
ENST00000393928.1 |
LEPREL4 |
leprecan-like 4 |
chr4_-_186456652 | 0.41 |
ENST00000284767.5 ENST00000284770.5 |
PDLIM3 |
PDZ and LIM domain 3 |
chr7_+_114562172 | 0.41 |
ENST00000393486.1 ENST00000257724.3 |
MDFIC |
MyoD family inhibitor domain containing |
chr6_+_116692102 | 0.41 |
ENST00000359564.2 |
DSE |
dermatan sulfate epimerase |
chr19_-_44174330 | 0.40 |
ENST00000340093.3 |
PLAUR |
plasminogen activator, urokinase receptor |
chr15_-_22448819 | 0.40 |
ENST00000604066.1 |
IGHV1OR15-1 |
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr2_+_219081817 | 0.40 |
ENST00000315717.5 ENST00000420104.1 ENST00000295685.10 |
ARPC2 |
actin related protein 2/3 complex, subunit 2, 34kDa |
chr10_-_112678976 | 0.39 |
ENST00000448814.1 |
BBIP1 |
BBSome interacting protein 1 |
chr14_-_24664540 | 0.38 |
ENST00000530563.1 ENST00000528895.1 ENST00000528669.1 ENST00000532632.1 |
TM9SF1 |
transmembrane 9 superfamily member 1 |
chr19_-_44174305 | 0.38 |
ENST00000601723.1 ENST00000339082.3 |
PLAUR |
plasminogen activator, urokinase receptor |
chr15_-_35088340 | 0.38 |
ENST00000290378.4 |
ACTC1 |
actin, alpha, cardiac muscle 1 |
chr2_-_191878874 | 0.36 |
ENST00000392322.3 ENST00000392323.2 ENST00000424722.1 ENST00000361099.3 |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
chr11_+_69455855 | 0.36 |
ENST00000227507.2 ENST00000536559.1 |
CCND1 |
cyclin D1 |
chr8_-_134584092 | 0.35 |
ENST00000522652.1 |
ST3GAL1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
chr20_-_24973318 | 0.35 |
ENST00000447138.1 |
APMAP |
adipocyte plasma membrane associated protein |
chr8_-_134584152 | 0.34 |
ENST00000521180.1 ENST00000517668.1 ENST00000319914.5 |
ST3GAL1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
chr3_+_160117087 | 0.34 |
ENST00000357388.3 |
SMC4 |
structural maintenance of chromosomes 4 |
chr22_+_24823517 | 0.33 |
ENST00000496258.1 ENST00000337539.7 |
ADORA2A |
adenosine A2a receptor |
chr17_-_15165854 | 0.32 |
ENST00000395936.1 ENST00000395938.2 |
PMP22 |
peripheral myelin protein 22 |
chr17_-_39968855 | 0.32 |
ENST00000355468.3 ENST00000590496.1 |
LEPREL4 |
leprecan-like 4 |
chr19_-_39108568 | 0.31 |
ENST00000586296.1 |
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
chr3_-_79068594 | 0.31 |
ENST00000436010.2 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
chr9_-_123676827 | 0.31 |
ENST00000546084.1 |
TRAF1 |
TNF receptor-associated factor 1 |
chr10_+_95256356 | 0.31 |
ENST00000371485.3 |
CEP55 |
centrosomal protein 55kDa |
chr17_-_35969409 | 0.30 |
ENST00000394378.2 ENST00000585472.1 ENST00000591288.1 ENST00000502449.2 ENST00000345615.4 ENST00000346661.4 ENST00000585689.1 ENST00000339208.6 |
SYNRG |
synergin, gamma |
chr10_-_112678692 | 0.30 |
ENST00000605742.1 |
BBIP1 |
BBSome interacting protein 1 |
chr11_+_61447845 | 0.30 |
ENST00000257215.5 |
DAGLA |
diacylglycerol lipase, alpha |
chr10_-_112678904 | 0.30 |
ENST00000423273.1 ENST00000436562.1 ENST00000447005.1 ENST00000454061.1 |
BBIP1 |
BBSome interacting protein 1 |
chr6_+_26383404 | 0.30 |
ENST00000416795.2 ENST00000494184.1 |
BTN2A2 |
butyrophilin, subfamily 2, member A2 |
chr12_-_49351228 | 0.30 |
ENST00000541959.1 ENST00000447318.2 |
ARF3 |
ADP-ribosylation factor 3 |
chr1_+_32716840 | 0.29 |
ENST00000336890.5 |
LCK |
lymphocyte-specific protein tyrosine kinase |
chr5_+_35856951 | 0.29 |
ENST00000303115.3 ENST00000343305.4 ENST00000506850.1 ENST00000511982.1 |
IL7R |
interleukin 7 receptor |
chr11_-_58345569 | 0.29 |
ENST00000528954.1 ENST00000528489.1 |
LPXN |
leupaxin |
chr19_+_13049413 | 0.29 |
ENST00000316448.5 ENST00000588454.1 |
CALR |
calreticulin |
chr1_-_205290865 | 0.28 |
ENST00000367157.3 |
NUAK2 |
NUAK family, SNF1-like kinase, 2 |
chr5_+_140772381 | 0.28 |
ENST00000398604.2 |
PCDHGA8 |
protocadherin gamma subfamily A, 8 |
chr11_+_19138670 | 0.28 |
ENST00000446113.2 ENST00000399351.3 |
ZDHHC13 |
zinc finger, DHHC-type containing 13 |
chr1_+_32716857 | 0.28 |
ENST00000482949.1 ENST00000495610.2 |
LCK |
lymphocyte-specific protein tyrosine kinase |
chr3_+_101498269 | 0.27 |
ENST00000491511.2 |
NXPE3 |
neurexophilin and PC-esterase domain family, member 3 |
chr17_+_25958174 | 0.27 |
ENST00000313648.6 ENST00000577392.1 ENST00000584661.1 ENST00000413914.2 |
LGALS9 |
lectin, galactoside-binding, soluble, 9 |
chr14_-_45603657 | 0.27 |
ENST00000396062.3 |
FKBP3 |
FK506 binding protein 3, 25kDa |
chr1_-_25256368 | 0.27 |
ENST00000308873.6 |
RUNX3 |
runt-related transcription factor 3 |
chr6_+_391739 | 0.27 |
ENST00000380956.4 |
IRF4 |
interferon regulatory factor 4 |
chrX_+_12885183 | 0.26 |
ENST00000380659.3 |
TLR7 |
toll-like receptor 7 |
chr9_+_134378289 | 0.25 |
ENST00000423007.1 ENST00000404875.2 ENST00000441334.1 ENST00000341012.7 ENST00000372228.3 ENST00000402686.3 ENST00000419118.2 ENST00000541219.1 ENST00000354713.4 ENST00000418774.1 ENST00000415075.1 ENST00000448212.1 ENST00000430619.1 |
POMT1 |
protein-O-mannosyltransferase 1 |
chr1_+_38022513 | 0.25 |
ENST00000296218.7 |
DNALI1 |
dynein, axonemal, light intermediate chain 1 |
chr19_-_51875523 | 0.25 |
ENST00000593572.1 ENST00000595157.1 |
NKG7 |
natural killer cell group 7 sequence |
chr12_+_4714145 | 0.25 |
ENST00000545342.1 |
DYRK4 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 |
chr4_-_90756769 | 0.25 |
ENST00000345009.4 ENST00000505199.1 ENST00000502987.1 |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
chr6_+_80816342 | 0.24 |
ENST00000369760.4 ENST00000356489.5 ENST00000320393.6 |
BCKDHB |
branched chain keto acid dehydrogenase E1, beta polypeptide |
chr1_+_161736072 | 0.24 |
ENST00000367942.3 |
ATF6 |
activating transcription factor 6 |
chr14_+_90864504 | 0.24 |
ENST00000544280.2 |
CALM1 |
calmodulin 1 (phosphorylase kinase, delta) |
chr9_+_90112117 | 0.24 |
ENST00000358077.5 |
DAPK1 |
death-associated protein kinase 1 |
chr11_-_6440624 | 0.24 |
ENST00000311051.3 |
APBB1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
chr14_-_75643296 | 0.23 |
ENST00000303575.4 |
TMED10 |
transmembrane emp24-like trafficking protein 10 (yeast) |
chr14_-_93651186 | 0.23 |
ENST00000556883.1 ENST00000298894.4 |
MOAP1 |
modulator of apoptosis 1 |
chr12_-_56120838 | 0.23 |
ENST00000548160.1 |
CD63 |
CD63 molecule |
chr15_-_52483566 | 0.23 |
ENST00000261837.7 |
GNB5 |
guanine nucleotide binding protein (G protein), beta 5 |
chr15_-_75165651 | 0.22 |
ENST00000562363.1 ENST00000564529.1 ENST00000268099.9 |
SCAMP2 |
secretory carrier membrane protein 2 |
chr6_-_52705641 | 0.22 |
ENST00000370989.2 |
GSTA5 |
glutathione S-transferase alpha 5 |
chr3_-_125094093 | 0.22 |
ENST00000484491.1 ENST00000492394.1 ENST00000471196.1 ENST00000468369.1 ENST00000544464.1 ENST00000485866.1 ENST00000360647.4 |
ZNF148 |
zinc finger protein 148 |
chr5_-_68628543 | 0.22 |
ENST00000396496.2 ENST00000511257.1 ENST00000383374.2 |
CCDC125 |
coiled-coil domain containing 125 |
chr5_+_66124590 | 0.22 |
ENST00000490016.2 ENST00000403666.1 ENST00000450827.1 |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
chr19_-_39108643 | 0.22 |
ENST00000396857.2 |
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
chr9_+_2157655 | 0.22 |
ENST00000452193.1 |
SMARCA2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr14_+_21249200 | 0.22 |
ENST00000304677.2 |
RNASE6 |
ribonuclease, RNase A family, k6 |
chr19_-_51875894 | 0.22 |
ENST00000600427.1 ENST00000595217.1 ENST00000221978.5 |
NKG7 |
natural killer cell group 7 sequence |
chr17_-_8066843 | 0.21 |
ENST00000404970.3 |
VAMP2 |
vesicle-associated membrane protein 2 (synaptobrevin 2) |
chr11_-_44972476 | 0.21 |
ENST00000527685.1 ENST00000308212.5 |
TP53I11 |
tumor protein p53 inducible protein 11 |
chr19_-_39108552 | 0.20 |
ENST00000591517.1 |
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
chr1_-_207095212 | 0.20 |
ENST00000420007.2 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
chr19_-_45982076 | 0.20 |
ENST00000423698.2 |
ERCC1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
chr13_-_99630233 | 0.20 |
ENST00000376460.1 ENST00000442173.1 |
DOCK9 |
dedicator of cytokinesis 9 |
chrX_-_119709637 | 0.20 |
ENST00000404115.3 |
CUL4B |
cullin 4B |
chr6_+_26383318 | 0.20 |
ENST00000469230.1 ENST00000490025.1 ENST00000356709.4 ENST00000352867.2 ENST00000493275.1 ENST00000472507.1 ENST00000482536.1 ENST00000432533.2 ENST00000482842.1 |
BTN2A2 |
butyrophilin, subfamily 2, member A2 |
chr9_-_20622478 | 0.19 |
ENST00000355930.6 ENST00000380338.4 |
MLLT3 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chr8_-_19459993 | 0.19 |
ENST00000454498.2 ENST00000520003.1 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
chr1_-_113247543 | 0.19 |
ENST00000414971.1 ENST00000534717.1 |
RHOC |
ras homolog family member C |
chr19_-_43702231 | 0.19 |
ENST00000597374.1 ENST00000599371.1 |
PSG4 |
pregnancy specific beta-1-glycoprotein 4 |
chr6_-_31651817 | 0.19 |
ENST00000375863.3 ENST00000375860.2 |
LY6G5C |
lymphocyte antigen 6 complex, locus G5C |
chr22_+_38201114 | 0.18 |
ENST00000340857.2 |
H1F0 |
H1 histone family, member 0 |
chr4_-_90759440 | 0.18 |
ENST00000336904.3 |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
chr16_+_27413483 | 0.18 |
ENST00000337929.3 ENST00000564089.1 |
IL21R |
interleukin 21 receptor |
chr5_-_137514333 | 0.18 |
ENST00000411594.2 ENST00000430331.1 |
BRD8 |
bromodomain containing 8 |
chr3_+_25469802 | 0.18 |
ENST00000330688.4 |
RARB |
retinoic acid receptor, beta |
chr7_+_35840819 | 0.18 |
ENST00000399035.3 |
SEPT7 |
septin 7 |
chr9_+_34990219 | 0.18 |
ENST00000541010.1 ENST00000454002.2 ENST00000545841.1 |
DNAJB5 |
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr7_+_107220660 | 0.18 |
ENST00000465919.1 ENST00000445771.2 ENST00000479917.1 ENST00000421217.1 ENST00000457837.1 |
BCAP29 |
B-cell receptor-associated protein 29 |
chr16_+_12058961 | 0.18 |
ENST00000053243.1 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr11_-_14380664 | 0.18 |
ENST00000545643.1 ENST00000256196.4 |
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2 |
chr7_-_87849340 | 0.17 |
ENST00000419179.1 ENST00000265729.2 |
SRI |
sorcin |
chr7_+_107220899 | 0.17 |
ENST00000379117.2 ENST00000473124.1 |
BCAP29 |
B-cell receptor-associated protein 29 |
chr13_-_46543805 | 0.17 |
ENST00000378921.2 |
ZC3H13 |
zinc finger CCCH-type containing 13 |
chr7_+_35840542 | 0.17 |
ENST00000435235.1 ENST00000399034.2 ENST00000350320.6 ENST00000469679.2 |
SEPT7 |
septin 7 |
chr19_+_55897297 | 0.17 |
ENST00000431533.2 ENST00000428193.2 ENST00000558815.1 ENST00000560583.1 ENST00000560055.1 ENST00000559463.1 |
RPL28 |
ribosomal protein L28 |
chr6_-_84937314 | 0.16 |
ENST00000257766.4 ENST00000403245.3 |
KIAA1009 |
KIAA1009 |
chr2_+_29338236 | 0.16 |
ENST00000320081.5 |
CLIP4 |
CAP-GLY domain containing linker protein family, member 4 |
chr16_+_12059050 | 0.16 |
ENST00000396495.3 |
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
chr12_-_56121612 | 0.16 |
ENST00000546939.1 |
CD63 |
CD63 molecule |
chr7_+_872107 | 0.16 |
ENST00000405266.1 ENST00000401592.1 ENST00000403868.1 ENST00000425407.2 |
SUN1 |
Sad1 and UNC84 domain containing 1 |
chr1_-_146040968 | 0.16 |
ENST00000401010.3 |
NBPF11 |
neuroblastoma breakpoint family, member 11 |
chr12_-_56121580 | 0.16 |
ENST00000550776.1 |
CD63 |
CD63 molecule |
chr11_+_62379194 | 0.16 |
ENST00000525801.1 ENST00000534093.1 |
ROM1 |
retinal outer segment membrane protein 1 |
chr6_+_30034966 | 0.16 |
ENST00000376769.2 |
PPP1R11 |
protein phosphatase 1, regulatory (inhibitor) subunit 11 |
chr1_+_16767167 | 0.15 |
ENST00000337132.5 |
NECAP2 |
NECAP endocytosis associated 2 |
chrX_+_70338366 | 0.15 |
ENST00000333646.6 |
MED12 |
mediator complex subunit 12 |
chr1_-_183387723 | 0.15 |
ENST00000287713.6 |
NMNAT2 |
nicotinamide nucleotide adenylyltransferase 2 |
chr12_-_12849073 | 0.15 |
ENST00000332427.2 ENST00000540796.1 |
GPR19 |
G protein-coupled receptor 19 |
chr1_+_16767195 | 0.15 |
ENST00000504551.2 ENST00000457722.2 ENST00000406746.1 ENST00000443980.2 |
NECAP2 |
NECAP endocytosis associated 2 |
chr1_+_155099927 | 0.15 |
ENST00000368407.3 |
EFNA1 |
ephrin-A1 |
chr22_-_42342733 | 0.15 |
ENST00000402420.1 |
CENPM |
centromere protein M |
chr9_+_17135016 | 0.15 |
ENST00000425824.1 ENST00000262360.5 ENST00000380641.4 |
CNTLN |
centlein, centrosomal protein |
chr11_-_6633799 | 0.15 |
ENST00000299424.4 |
TAF10 |
TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa |
chr19_-_46000251 | 0.14 |
ENST00000590526.1 ENST00000344680.4 ENST00000245923.4 |
RTN2 |
reticulon 2 |
chr17_+_46184911 | 0.14 |
ENST00000580219.1 ENST00000452859.2 ENST00000393405.2 ENST00000439357.2 ENST00000359238.2 |
SNX11 |
sorting nexin 11 |
chr7_-_48019101 | 0.14 |
ENST00000432627.1 ENST00000258774.5 ENST00000432325.1 ENST00000446009.1 |
HUS1 |
HUS1 checkpoint homolog (S. pombe) |
chr19_-_51192661 | 0.14 |
ENST00000391813.1 |
SHANK1 |
SH3 and multiple ankyrin repeat domains 1 |
chr6_+_292459 | 0.14 |
ENST00000419235.2 ENST00000605035.1 ENST00000605863.1 |
DUSP22 |
dual specificity phosphatase 22 |
chr3_+_32726774 | 0.14 |
ENST00000538368.1 |
CNOT10 |
CCR4-NOT transcription complex, subunit 10 |
chr6_+_30035307 | 0.14 |
ENST00000376765.2 ENST00000376763.1 |
PPP1R11 |
protein phosphatase 1, regulatory (inhibitor) subunit 11 |
chr13_+_27825706 | 0.14 |
ENST00000272274.4 ENST00000319826.4 ENST00000326092.4 |
RPL21 |
ribosomal protein L21 |
chr12_-_56120865 | 0.14 |
ENST00000548898.1 ENST00000552067.1 |
CD63 |
CD63 molecule |
chr12_-_49351303 | 0.14 |
ENST00000256682.4 |
ARF3 |
ADP-ribosylation factor 3 |
chr12_-_56122220 | 0.14 |
ENST00000552692.1 |
CD63 |
CD63 molecule |
chr14_-_55658323 | 0.13 |
ENST00000554067.1 ENST00000247191.2 |
DLGAP5 |
discs, large (Drosophila) homolog-associated protein 5 |
chr1_-_1009683 | 0.13 |
ENST00000453464.2 |
RNF223 |
ring finger protein 223 |
chr3_+_98250743 | 0.13 |
ENST00000284311.3 |
GPR15 |
G protein-coupled receptor 15 |
chr2_+_5832799 | 0.13 |
ENST00000322002.3 |
SOX11 |
SRY (sex determining region Y)-box 11 |
chrX_+_70338552 | 0.13 |
ENST00000374080.3 ENST00000429213.1 |
MED12 |
mediator complex subunit 12 |
chr9_+_17134980 | 0.13 |
ENST00000380647.3 |
CNTLN |
centlein, centrosomal protein |
chr12_+_124155652 | 0.12 |
ENST00000426174.2 ENST00000303372.5 |
TCTN2 |
tectonic family member 2 |
chr22_-_31688431 | 0.12 |
ENST00000402249.3 ENST00000443175.1 ENST00000215912.5 ENST00000441972.1 |
PIK3IP1 |
phosphoinositide-3-kinase interacting protein 1 |
chr12_-_57522813 | 0.12 |
ENST00000556155.1 |
STAT6 |
signal transducer and activator of transcription 6, interleukin-4 induced |
chr11_+_1940786 | 0.12 |
ENST00000278317.6 ENST00000381561.4 ENST00000381548.3 ENST00000360603.3 ENST00000381549.3 |
TNNT3 |
troponin T type 3 (skeletal, fast) |
chr10_+_114135004 | 0.12 |
ENST00000393081.1 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
chr1_+_145507587 | 0.11 |
ENST00000330165.8 ENST00000369307.3 |
RBM8A |
RNA binding motif protein 8A |
chr2_-_85581701 | 0.11 |
ENST00000295802.4 |
RETSAT |
retinol saturase (all-trans-retinol 13,14-reductase) |
chr12_+_53443963 | 0.11 |
ENST00000546602.1 ENST00000552570.1 ENST00000549700.1 |
TENC1 |
tensin like C1 domain containing phosphatase (tensin 2) |
chr2_+_102759199 | 0.11 |
ENST00000409288.1 ENST00000410023.1 |
IL1R1 |
interleukin 1 receptor, type I |
chr4_-_90757364 | 0.11 |
ENST00000508895.1 |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
chr16_-_67493110 | 0.11 |
ENST00000602876.1 |
ATP6V0D1 |
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 |
chr17_+_58755184 | 0.11 |
ENST00000589222.1 ENST00000407086.3 ENST00000390652.5 |
BCAS3 |
breast carcinoma amplified sequence 3 |
chr16_+_31271274 | 0.11 |
ENST00000287497.8 ENST00000544665.3 |
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit) |
chr7_-_35077653 | 0.11 |
ENST00000310974.4 |
DPY19L1 |
dpy-19-like 1 (C. elegans) |
chr12_-_56122761 | 0.11 |
ENST00000552164.1 ENST00000420846.3 ENST00000257857.4 |
CD63 |
CD63 molecule |
chr7_+_5919458 | 0.11 |
ENST00000416608.1 |
OCM |
oncomodulin |
chr3_+_183967409 | 0.10 |
ENST00000324557.4 ENST00000402825.3 |
ECE2 |
endothelin converting enzyme 2 |
chr1_+_202995611 | 0.10 |
ENST00000367240.2 |
PPFIA4 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 1.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.6 | 1.7 | GO:0043132 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) NAD transport(GO:0043132) |
0.4 | 1.2 | GO:0061010 | gall bladder development(GO:0061010) |
0.3 | 2.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 1.3 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.2 | 0.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 1.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.7 | GO:2000525 | dendritic cell dendrite assembly(GO:0097026) regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.2 | 0.6 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.2 | 0.6 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
0.2 | 0.5 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
0.2 | 0.5 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 1.1 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 0.5 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.1 | 0.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.4 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.8 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.9 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.1 | 1.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 | 0.8 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.3 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.9 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.3 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 0.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.2 | GO:0045082 | interleukin-4 biosynthetic process(GO:0042097) positive regulation of interleukin-10 biosynthetic process(GO:0045082) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.8 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.2 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.1 | 0.2 | GO:1901189 | arterial endothelial cell fate commitment(GO:0060844) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 1.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.2 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.1 | 0.2 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.1 | 0.5 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.1 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.1 | 0.7 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.3 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.1 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.2 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.1 | 0.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 1.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.3 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.2 | GO:0061030 | axon target recognition(GO:0007412) epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.3 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.1 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.1 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.0 | 0.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.6 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.0 | 0.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 1.9 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.0 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.1 | GO:1903464 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.0 | 0.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.0 | 0.2 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.0 | 0.2 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.1 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.0 | 2.1 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.4 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.1 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.0 | 0.1 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.1 | GO:0043449 | olfactory learning(GO:0008355) cellular alkene metabolic process(GO:0043449) |
0.0 | 0.1 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.0 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.0 | 0.1 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.0 | 0.2 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.2 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.0 | 0.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.6 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.0 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.2 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.0 | 0.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.0 | 1.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.2 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.0 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.3 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.0 | GO:1905071 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.0 | 0.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.0 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.0 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.0 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.1 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.0 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.0 | 0.1 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.0 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 1.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.0 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.7 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 1.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.2 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 1.3 | GO:0090244 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) negative regulation of cell fate specification(GO:0009996) Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.4 | 1.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 0.9 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.2 | 1.2 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.2 | 0.6 | GO:0006788 | heme oxidation(GO:0006788) smooth muscle hyperplasia(GO:0014806) |
0.2 | 0.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.2 | 0.6 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.2 | 1.1 | GO:1902998 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.2 | 0.5 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.1 | 0.7 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 1.4 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.6 | GO:0048861 | oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 1.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.7 | GO:0051582 | peptidyl-cysteine methylation(GO:0018125) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
0.1 | 0.4 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 1.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.3 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
0.1 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.3 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
0.1 | 0.4 | GO:2000697 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
0.1 | 0.3 | GO:0045082 | interleukin-4 biosynthetic process(GO:0042097) positive regulation of interleukin-10 biosynthetic process(GO:0045082) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 1.1 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 2.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.2 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.1 | 0.3 | GO:0099541 | retrograde trans-synaptic signaling(GO:0098917) trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
0.1 | 0.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.3 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.1 | 0.4 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.3 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.0 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.0 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.0 | 0.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.1 | GO:0050894 | determination of affect(GO:0050894) |
0.0 | 0.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.0 | 0.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.2 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.1 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.4 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.3 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.2 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.0 | 0.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.9 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.2 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.0 | 0.1 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.0 | 0.1 | GO:0051039 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.0 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 1.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.0 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.7 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.7 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:0061317 | regulation of Wnt signaling pathway involved in heart development(GO:0003307) canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
0.0 | 0.2 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.1 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.0 | 0.1 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.0 | 0.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.7 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.0 | 0.3 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 0.1 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.0 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.0 | 0.1 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.0 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 2.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.5 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.1 | GO:0010827 | regulation of glucose transport(GO:0010827) regulation of glucose import(GO:0046324) |
0.0 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0016050 | vesicle organization(GO:0016050) |
0.0 | 0.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.4 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.2 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.0 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 2.9 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.4 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.0 | 0.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.2 | 0.5 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.1 | 0.7 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.3 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.1 | 2.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.4 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.1 | 1.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 1.7 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 0.2 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.1 | 0.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.3 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.0 | 1.0 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.5 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.1 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.2 | 0.6 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 0.6 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) oncostatin-M receptor activity(GO:0004924) interleukin-6 binding(GO:0019981) |
0.2 | 0.9 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.1 | 0.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.4 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.5 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 1.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) sphingolipid binding(GO:0046625) |
0.1 | 1.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 1.2 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 1.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.3 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.1 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.2 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.1 | 0.2 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 3.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.6 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 0.2 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 0.7 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 1.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.0 | 1.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 1.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.0 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 2.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:1901474 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 1.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.0 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.0 | 0.1 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.4 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.6 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.0 | 0.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 1.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 1.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 2.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 1.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 3.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 1.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 1.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.4 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 0.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 1.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.5 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 1.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 1.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.9 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.6 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 2.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.6 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 1.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.6 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.0 | 0.8 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.4 | GO:1990023 | kinetochore microtubule(GO:0005828) mitotic spindle midzone(GO:1990023) |
0.0 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 2.3 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 1.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.2 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.0 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0051185 | FAD transmembrane transporter activity(GO:0015230) coenzyme transporter activity(GO:0051185) |
0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 1.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 0.5 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.1 | 2.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.5 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 0.3 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 0.6 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.5 | GO:0008948 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 1.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 1.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.2 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 1.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 1.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.0 | 0.1 | GO:0004307 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.3 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 1.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 2.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 1.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.5 | GO:0097493 | muscle alpha-actinin binding(GO:0051371) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.0 | 0.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.0 | 0.1 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.0 | 1.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.3 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.0 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 1.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 1.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 1.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.2 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.1 | 0.2 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.1 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 1.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.4 | GO:0051183 | vitamin transporter activity(GO:0051183) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 1.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.6 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 1.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.4 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.1 | 1.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.7 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 2.5 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.3 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.0 | 0.1 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.0 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 1.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.8 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 2.5 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 1.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 1.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 1.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 1.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 2.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 1.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 2.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 2.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | PID RAS PATHWAY | Regulation of Ras family activation |